Ketamine for the Treatment of Psychiatric Disorders: A Systematic Review and Meta-Analysis.
CNS Spectrums November 20, 2024 Angela T H Kwan, Moiz Lakhani, Gurkaran Singh et al. 4 citations
Inadequate response to first- and second-line pharmacological treatments for psychiatric disorders is commonly observed. Ketamine has demonstrated efficacy in treating adults with treatment-resistant depression (TRD), with additional off-label benefits reported for various psychiatric disorders. Herein, we performed a systematic review and meta-analysis to examine the therapeutic applications...
DOI: 10.1017/S1092852924000580 (opens in new tab)
Full text (opens in new tab)
Anxiety disorders
Eating disorders
Schizophrenia
Substance/alcohol use disorders
+5